LIDOCAINE HYDROCHLORIDE INJECTION USP
PFIZER CANADA ULC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of LIDOCAINE HYDROCHLORIDE INJECTION USP in Canada?
A shortage of LIDOCAINE HYDROCHLORIDE INJECTION USP 20MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated May 11, 2026), but it has not started yet.
Why is LIDOCAINE HYDROCHLORIDE INJECTION USP not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will LIDOCAINE HYDROCHLORIDE INJECTION USP be available again?
The manufacturer's estimated resolution date is June 15, 2027. This is an estimate and can change; follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
XYLOCAINE JELLY 2%
ASPEN PHARMACARE CANADA INC.
LIDOCAINE HCL INJ 20MG/ML
INTERNATIONAL MEDICATION SYSTEMS LTD.
XYLOCAINE 2% EPIDURAL
ASTRAZENECA CANADA INC
PREATTACHED LTA KIT
HOSPIRA HEALTHCARE ULC
XYLOCARD
ASPEN PHARMACARE CANADA INC.
XYLOCAINE MPF 1%
ASTRAZENECA L.P.
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.
⚠ Possible Recall or Safety Alert
Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.
Lidocaine Hydrochloride and Epinephrine Injection USP
Lidocaine Hydrochloride and Epinephrine Injection USP: Affected lot may contain particles.
Highest health risk
Possible match — not confirmed
0.4% Lidocaine Hydrochloride & 5% Dextrose Injection
0.4% Lidocaine Hydrochloride & 5% Dextrose Injection: Solution bags may be leaking in affected lots. (Updated with new lot numbers)
Highest health risk
Possible match — not confirmed
DIN
00436208
Strength
20MG
Dosage Form
SOLUTION
Route
INTRAVENOUS
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Disruption of the manufacture of the drug.
Business reasons
Other Products from PFIZER CANADA ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
40MG · DIN 02511053
20MG · DIN 02511061
40MG · DIN 02511045
DIN 02544040
5MG · DIN 01947664
10MG · DIN 01947672
20MG · DIN 01947680
40MG · DIN 01947699
DIN 02237367
DIN 02237368
DIN 02237369
50MG · DIN 02401347